Lesion Cohorta (n = 516) | Patient Cohorta (n = 120) | Median Survival (mo) | |
---|---|---|---|
Age | |||
Median | 59.7 yr | ||
Range | 31–89 yr | ||
Sex | |||
Male | 53 (44%) | ||
Female | 67 (56%) | ||
Race | |||
Caucasian | 106 (88%) | ||
Other | 14 (12%) | ||
Primary pathology | |||
NSCLCa | 175 (34%) | 47 (39%) | 11.8 |
SCLCa | 20 (4%) | 6 (5%) | 6.8 |
Breast | 116 (22%) | 18 (15%) | 12.3 |
Melanoma | 123 (24%) | 24 (20%) | 13.7 |
Renal | 51 (10%) | 11 (9%) | 8.5 |
Colon | 13 (2.5%) | 6 (5%) | 13.0 |
Other | 18 (3.5%) | 8 (7%) | 10.0 |
Radiosensitiveb | 342 (66%) | 85 (71%) | 12.3 |
Radioresistantc | 174 (34%) | 35 (29%) | 12.9 |